Difference between revisions of "Riverso M, et al. Oncogene (2017) cited as Ref 106 in DOI: 10.1038/s41392-020-0110-5 (Q9369)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Riverso M, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 3322-3333, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (8 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Montagnani V | ||||||||||||||
| Property / Second Author string: Montagnani V / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Stecca B | ||||||||||||||
| Property / Third Author string: Stecca B / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1038/onc.2016.481 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 28068326 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2017
| ||||||||||||||
| Property / Publication Date: 2017 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Oncogene | ||||||||||||||
| Property / Published In Name String: Oncogene / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 36 | ||||||||||||||
| Property / Volume: 36 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth (English) | ||||||||||||||
| Property / title: KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 3322-3333 | ||||||||||||||
| Property / Page(s): 3322-3333 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:30, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Riverso M, et al. Oncogene (2017) cited as Ref 106 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Riverso M
0 references
Montagnani V
0 references
Stecca B
0 references
2017
0 references
Oncogene
0 references
36
0 references
KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth (English)
0 references
3322-3333
0 references
